Claris Biotherapeutics
Jersey City, NJ
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.
clarisbio.comCompany Details
Founded
- 2018
Employees
- Between 2 - 10 employees
Raised
- $101,499,992
Headquarters Location
- Jersey City, NJ
Public
- No
Acquired
- No
CEO
Clarke Atwell
Founders
- Sunil ChauhanReza Dana
Company Collections
These are collections Claris Biotherapeutics is a part of. Click on the collection name to view similar companies.